Table 2.

Multivariable Logistic Regression for HBV Screening and Vaccination among Chinese Americans^a

	Screening				Vaccination
	Males (n=264)		Females (n=206)		Males (n=230)		Females (n=197)
	OR (95% CI)	p-value	OR (95% CI)	p-value	OR (95% CI)	p-value	OR (95% CI)	p-value
Socio-demographics
Age (continuous)	0.99 (0.96, 1.01)	.295	1.00 (0.98, 1.03)	.944	0.97 (0.93, 1.00)	.047	0.98 (0.95, 1.01)	.129
Education (Ref=<High school)
High school/vocational school	0.9 (0.5, 1.9)	.839	1.5 (0.5, 3.9)	.459	3.2 (1.2, 8.0)	.015	1.7 (0.6, 4.3)	.290
≥ College graduate	2.1 (0.7, 6.1)	.163	1.6 (0.4, 5.6)	.481	2.8 (0.8, 9.1)	.092	1.5 (0.4, 5.5)	.539
Percent of lifetime lived in US (Ref=>50%)
<20%	2.0 (0.6, 6.5)	.244	2.5 (0.8, 7.6)	.103	0.7 (0.2, 2.7)	.594	3.4 (1.0, 11.9)	.059
20–50%	1.5 (0.5, 4.8)	.525	2.2 (0.8, 6.3)	.133	0.3 (0.1, 1.3)	.115	0.7 (0.2, 2.3)	.601
Resource and provider barriers
Insured	2.5 (1.3, 5.0)	.009	0.5 (0.2, 1.4)	.224	1.8 (0.8, 3.9)	.165	1.2 (0.5, 3.0)	.766
Physician screening/vaccination recommendation	13.7 (5.6, 33.6)	< .001	12.3 (5.4, 28.1)	< .001	47.0 (17.1, 129.3)	< .001	15.6 (6.9, 35.4)	< .001
HBV Knowledge
Heard of HBV	4.9 (1.9, 12.3)	.001	2.2 (0.6, 7.9)	.243	7.2 (2.0, 26.0)	.003	1.4 (0.3, 6.0)	.672
Knowledge scale	1.14 (1.00, 1.30)	.056	1.1 (0.9, 1.3)	.518	0.94 (0.80, 1.10)	.425	1.0 (0.9, 1.2)	.895

^aLogistic models adjusted for all variables in the table, significance set at p ≤ .05